Mankind Pharma Share Price

NSE: MANKIND
|
Pharmaceuticals

₹ 2,352.10

+₹17.10 (0.73%)
1D
Last updated 15 Oct, 2026, 11:19 IST

Mankind Pharma Share Price Today

As of 15 Oct 2026, Mankind Pharma share price is ₹2,352.10. The stock opened at ₹2,325.60, compared to its previous close of ₹2,335.00. During today's trading session, Mankind Pharma share price moved in the range of ₹2,321.10 to ₹2,365.00, with an average price of ₹2,343.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,909.70 and a high of ₹2,642.00. On the performance front, Mankind Pharma share price has increased by 12.40% over the last six months and is down 4.23% on a year-on-year basis.

₹2,321.10
0.73% up today
₹2,365.00
1D LOW
1D HIGH

Mankind Pharma Returns Calculator

Volume
2,19,000
Average traded price
₹2,353.16
Last traded time
11:19:30 15 Oct
Last traded quantity
10
Circuit
L
H
₹2,101.50
₹2,568.50
52-week
L
H
₹1,909.70
₹2,642.00
Mkt Cap Cr
96,243.64
P/E
47.32
P/B
6.0
ROA
7.36%
ROE
11.74%
ROCE
13.13%
Quick Ratio
0.74
EV/EBITDA
26.02
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Mankind Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Mankind Pharma appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Mankind Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,19,619.6935.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,10,823.44101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,07,446.7932.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46
Glenmark Pharma63,980.3335.596.099.03%28.08%32.7%1.2319.04

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Mankind Pharma

ISIN
INE634S01028
Sector Market Cap
₹ 96,243.64 Cr

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It also offers pet care, crop protection solutions, and veterinary care. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/central nervous system, vitamins, minerals and nutrients, derma, fertility, and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.

Mankind Pharma Financial Highlights

  • Revenue: Mankind Pharma reported revenue of ₹14,636.43 crore in FY26 vs ₹12,744.23 crore in FY25. It showed an increase of 14.85% on a yearly basis.
  • Operating Profit: Mankind Pharma reported an operating profit of ₹2,332.68 crore in FY26 vs ₹2,516.33 crore in FY25. It showed a decrease of 7.30% on a year-on-year basis.
  • Net Profit: Mankind Pharma reported a net profit of ₹1,938.10 crore in FY26 vs ₹2,011.12 crore in FY25. It showed a decrease of 3.63% on a yearly basis.

Mankind Pharma Quarterly Result Highlights

  • Mankind Pharma reported revenue of ₹4,075.59 crore in Jun 2026, compared with ₹3,557.22 crore in Mar 2026, representing an increase of 14.57% on a quarter-on-quarter (QoQ) basis.
  • Mankind Pharma reported an operating profit of ₹769.45 crore in Jun 2026, compared with ₹659.17 crore in Mar 2026, representing an increase of 16.73% on a quarter-on-quarter (QoQ) basis.
  • Mankind Pharma reported a profit of ₹574.09 crore in Jun 2026, compared with ₹559.42 crore in Mar 2026, reflecting an increase of 2.62% on a QoQ basis.
  • The earnings per share (EPS) of Mankind Pharma stood at ₹46.35 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.63%
FII
9.45%
Other DII
4.52%
Retail and other
2.53%
Mutual funds
10.87%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202512.84%
Dec 202511.34%
Mar 202610.24%
Jun 20269.45%
1 day
-1.56%
1 week
-6.60%
1 month
+2.41%
1 year
-4.23%
3 years
+30.49%
5 years
+64.17%
Day
Open / Close
Change %
14 Oct 26
₹2,372.00 / ₹2,335.00
-1.56%
13 Oct 26
₹2,400.00 / ₹2,372.00
-1.17%
12 Oct 26
₹2,368.50 / ₹2,400.00
+1.33%
09 Oct 26
₹2,380.00 / ₹2,368.50
-0.48%
Show more

Mankind Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹14,277.64₹12,207.44₹10,260.44₹8,749.43
Other Income₹358.79₹536.79₹280.22₹128.57
Total Revenue₹14,636.43₹12,744.23₹10,540.66₹8,878.00
Total Expenses₹12,185.69₹10,240.14₹8,157.93₹7,219.18
Profit Before Tax₹2,332.68₹2,516.33₹2,397.94₹1,671.24
Tax₹394.58₹509.74₹457.15₹361.56
Profit After Tax₹1,938.10₹2,006.59₹1,940.79₹1,309.68
EPS - Basic₹46.35₹49.28₹47.75₹32.00
EPS - Diluted₹46.28₹49.19₹47.68₹32.00

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,332.68₹2,524.78₹2,399.35₹1,671.24
Income before WC changes₹3,609.20₹3,126.57₹2,611.54₹1,969.67
Change in Assets-₹384.14-₹441.41-₹226.35₹222.73
Change in Liabilities₹488.96₹294.97₹208.78-₹56.00
Change in WC₹104.82-₹146.44-₹17.57₹166.73
Cash flow from Operations₹3,121.29₹2,413.38₹2,152.44₹1,813.30
Cash flow from Investing-₹196.42-₹12,682.95-₹2,081.69-₹1,054.13
Cash flow from Financing-₹2,952.69₹10,232.56₹5.27-₹739.73
Total Cash Flow-₹27.82-₹37.01₹76.02₹19.44
Cash (Start of the year)₹403.88₹382.01₹304.82₹283.06
Cash (End of the year)₹391.69₹403.88₹382.01₹304.82

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹21,125.33₹20,771.26₹5,395.03₹5,387.58
Current Assets₹6,954.20₹6,988.27₹6,568.22₹4,327.87
Total Assets₹28,079.53₹27,759.53₹11,963.25₹9,715.45
Current Liabilities₹6,507.25₹5,663.56₹2,119.73₹1,863.14
Net Current Asset₹446.95₹1,324.71₹4,448.49₹2,464.74
Non-Current Liabilities₹5,011.23₹7,527.79₹267.73₹229.02
Equity Capital₹16,561.05₹14,568.18₹9,575.79₹7,623.29
Total Equity & Liabilities₹28,079.53₹27,759.53₹11,963.25₹9,715.45

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10,421.18₹9,507.41₹8,629.25₹8,127.15
Other Income₹326.10₹493.42₹270.50₹162.78
Total Revenue₹10,747.28₹10,000.83₹8,899.75₹8,289.94
Total Expenses₹8,326.04₹7,854.33₹6,714.55₹6,727.10
Profit Before Tax₹2,315.00₹2,146.50₹2,185.20₹1,562.84
Tax₹277.44₹421.74₹412.57₹314.58
Profit After Tax₹2,037.56₹1,724.76₹1,772.63₹1,248.26
EPS - Basic₹49.37₹44.22₹46.84₹31.16
EPS - Diluted₹49.30₹44.13₹46.77₹31.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,315.00₹2,230.87₹2,325.72₹1,562.84
Income before WC changes₹3,046.49₹2,703.16₹2,490.46₹1,789.84
Change in Assets-₹138.57-₹186.47-₹583.75₹427.77
Change in Liabilities₹318.93₹304.93₹250.37-₹133.55
Change in WC₹180.36₹118.46-₹333.38₹294.21
Cash flow from Operations₹2,751.99₹2,350.14₹1,736.08₹1,798.99
Cash flow from Investing-₹387.96-₹12,114.46-₹1,665.19-₹1,040.61
Cash flow from Financing-₹2,476.92₹9,816.50-₹4.73-₹710.41
Total Cash Flow-₹112.89₹52.18₹66.16₹47.96
Cash (Start of the year)₹200.68₹211.62₹145.46₹86.17
Cash (End of the year)₹87.66₹200.66₹211.62₹134.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹20,439.48₹19,737.53₹5,886.84₹5,854.21
Current Assets₹4,185.83₹4,720.70₹5,629.55₹3,516.91
Total Assets₹24,625.31₹24,458.23₹11,516.39₹9,371.12
Current Liabilities₹5,473.19₹4,958.88₹1,616.56₹1,419.09
Net Current Asset-₹1,287.36-₹238.18₹4,012.99₹2,097.82
Non-Current Liabilities₹2,755.18₹5,176.63₹197.06₹168.12
Equity Capital₹16,396.94₹14,322.72₹9,702.77₹7,783.91
Total Equity & Liabilities₹24,625.31₹24,458.23₹11,516.39₹9,371.12
* All values are in INR Crore
Qty
Bid
192
2351.3
1
2350.8
13
2350.7
13
2350.6
48
2350.5
Ask
Qty
2352.1
26
2352.2
28
2352.3
12
2352.4
60
2352.5
18
Bid Total: 267
Ask Total: 144
Buy orders: 65%
Sell orders: 35%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.12
Neutral
ATR (14)
70.49
Neutral
STOCH(9,6)
7.89
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
29.68
Bearish
UO(9)
43.67
Neutral
ROC(12)
-5.65
Bearish
WillR(14)
-92.75
Bullish
Period
Simple value
Exponential vaue
5D
2371.1
2380.58
10D
2437.33
2408.08
20D
2427.92
2414.35
50D
2396.92
2412.91
100D
2433.04
2394.47
Volume trend — traded volume by day
15 Oct2L
14 Oct4L
13 Oct3L
12 Oct2L
9 Oct3L
8 Oct7L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Mankind Pharma
Pharmaceuticals
Add Stock
Add Another

Mankind Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.